Loading your page…
Diseases
By Elcadi K, Cherkaoui Rhazouani O, Louhab N and 2 others.
In Parkinson's disease (PD), non-motor symptoms especially anxiety represent a significant and underappreciated burden. Despite the lack of particular validation in this demographic, the Hamilton Anxiety Rating Scale (HAM-A) is widely used in clinical and research contexts.
Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.
A cross-sectional study of 200 Parkinson's disease patients (mean age 62.77 ± 8.32 years; 118 men and 82 females) was conducted. The Hoehn & Yahr (H&Y) scale was used to grade motor severity, whereas the HAM-A was used to measure anxiety.
Of the patients, 52.5% of people (n = 105; mean score 13.85 ± 6.09) had anxiety (HAM-A ≥ 14). Age (r = 0.032; p = 0.657), disease duration (r = 0.115; p = 0.105), H&Y stage (r = -0.073; p = 0.305), and sex (p = 0.856) did not significantly correlate with the HAM-A score.
Although the HAM-A shows a high incidence of anxiety in Parkinson's disease (PD), its consistent lack of connection with clinical illness markers raises serious concerns about construct validity, which are probably caused by somatic item overlap. It is best to use disease-specific tools like the GAD-7 or Parkinson Anxiety Scale (PAS).
Published in Diseases (Basel, Switzerland). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
